Arrowhead Research | ARWR - Ebitda





Ebitda Changement Date
Agios Pharmaceuticals USD -108.66M 11.65M 2026-03
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD -147.68M 40.33M 2026-06
Heron Therapeutics USD -3.88M 5.63M 2024-09
Incyte USD 778.57M 410.6M 2026-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Ligand Pharmaceuticals USD -14.3M 81.08M 2026-03
Merck USD -1.54B 7.84B 2026-03
Moderna USD -1.26B 468M 2026-03
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Novartis USD 6.48B 1.19B 2026-06
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
TG Therapeutics USD 26.9M 1.21M 2026-06
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06
Xencor USD -34.63M 86.74M 2026-06